Abstract
Objectives We examined variation in primary care physicians’ (PCPs’) perceptions of barriers to physician-initiated discussion of HPV vaccination, and how this is associated with the rates at which they discuss, initiate and continue to administer vaccination with 11–12 year-old girls. Methods We surveyed 301 PCPs using systematic random sampling. PCP variation in perceived barriers to discussing HPV vaccination was modeled using latent class analysis (LCA). The distinct PCP groups identified were compared with each other using three iterative logistic regression models to predict the likelihood of initiating vaccine discussion and the reported percentages of 11–12 year-old patients who initiated HPV vaccination and received follow-up shots. Results LCA revealed three groups of PCPs who perceived major, moderately significant and relatively minor barriers (17.9, 41.9 and 40.2 % of respondents, respectively). Pediatricians, PCPs who were female, had minority racial/ethnic status and who perceived only minor barriers had significantly higher odds of initiating discussion. PCPs were more likely to initiate HPV vaccination if they had initiated discussion and perceived minor or moderate communication barriers. Increased likelihood to administer follow-up HPV vaccine was associated with having initiated discussion, perceiving only minor barriers and working outside Deep South states, but not with having initiated vaccination. Conclusions for Practice PCPs who discuss HPV vaccination with girls aged 11–12 and their mothers are more likely to start and sustain vaccine administration. However, different PCPs perceive barriers to discussion in different ways. Interventions tailored to different groups of PCPs should assist them in overcoming barriers to discussing their recommendations when necessary.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
American Academy of Family Physicians (AAFP). (2015). Family medicine facts. (www.aafp.org/about/the-aafp/family-medicine-facts.html). Accessed 4 May 2015.
American Academy of Pediatrics (AAP). (2013). Pediatricians’ practice and personal characteristics: US only, 2013. (www.aap.org/en-us/professional-resources/Research/pediatrician-surveys/Pages/Personal-and-Practice-Characteristics-of-Pediatricians-US-only-2010.aspx). Accessed 4 May 2015.
Beck, R. S., Daughtridge, R., & Sloane, P. D. (2002). Physician-patient communication in the primary care office: a systematic review. Journal of the American Board of Family Medicine, 15(1), 25–38.
Cabana, M. D., Rand, C. S., Powe, N. R., et al. (1999). Why don’t physicians follow clinical practice guidelines? A framework for improvement. Journal of the American Medical Association, 282(15), 1458–1465.
Collins, L. M., & Lanza, S. T. (2012). Latent class and latent transition analysis: With applications in the social, behavioral and health sciences. New York, NY: Wiley.
Darden, P. M., Thompson, D. M., Roberts, J. R., et al. (2013). Reasons for not vaccinating adolescents: National Immunization Survey of Teens, 2008–2010. Pediatrics, 131(4), 645–651.
Elwyn, G., Frosch, D., Thomson, R., et al. (2012). Shared decision making: A model for clinical practice. Journal of General Internal Medicine, 27(10), 1361–1367.
Engels, G. L. (1977). The need for a new medical model: A challenge for biomedicine. Science, 196(4286), 129–136.
Epstein, R. M., Alper, B. S., & Quill, T. E. (2004). Communicating evidence for participatory decision making. JAMA, 291(19), 2359–2366.
Frieden, T. (2014). Protect the Next Generation: Recommend the HPV Vaccine. CDC Expert Commentary, Medscape, Aug 18, 2014. Available at http://www.medscape.com/viewarticle/829938. Accessed June 16, 2015.
Goff, S. L., Mazor, K. M., Gagne, S. J., Corey, K. C., et al. (2011). Vaccine counseling: A content analysis of patient–physician discussions regarding human papillomavirus vaccine. Vaccine, 29(43), 7343–7349.
Golin, C. E., Thorpe, C., & DiMatteo, M. R. (2007). Accessing the patient’s world: Patient-physician communication about psychosocial issues. In J. E. Earp, E. French, & M. Gilkey (Eds.), Patient advocacy for health care quality: Strategies for achieving patient-centered care (pp. 185–213). Sudbury, MA: Jones and Bartlett Inc.
Holman, D. M., Benard, V., Roland, K. B., et al. (2014). Barriers to human papillomavirus vaccination among US adolescents: A systematic review of the literature. JAMA Pediatrics, 168(1), 76–82.
Jemal, A., Simard, E. P., Dorrell, C., et al. (2013). Annual Report to the Nation on the Status of Cancer, 1975–2009, featuring the burden and trends in human papillomavirus (HPV)-associated cancers and HPV vaccination coverage levels. Journal of the National Cancer Institute, 105(3), 175–201.
Kester, L. M., Zimet, G. D., Fortenberry, J. D., Kahn, J. A., & Shew, M. L. (2013). A national study of HPV vaccination of adolescent girls: rates, predictors, and reasons for non-vaccination. Maternal and Child Health Journal, 17(5), 879–885.
Kramer, M. R., & Dunlop, A. L. (2012). Inter-state variation in human papilloma virus vaccine coverage among adolescent girls in the 50 US states, 2007. Maternal and Child Health Journal, 16(Suppl 1), S102–S110.
Kulczycki, A., Qu, H., Bosarge, P. M., & Shewchuk, R. M. (2010). Examining the diverse perspectives of nurse practitioners regarding obstacles to diaphragm prescription: A latent class analysis. Journal of Women’s Health, 19(7), 1355–1361.
Kulczycki, A., Qu, H., & Shewchuk, R. M. (2016). Primary care physicians’ adherence to guidelines and their likelihood to prescribe the human papillomavirus vaccine for 11-and 12-year-old girls. Women’s Health Issues, 26(1), 34–39.
Kulczycki, A., & Shewchuk, R. M. (2016). Quality of physician communication about HPV vaccine—Letter. Cancer Epidemiology, Biomarkers and Prevention, 25, 867.
Malo, T. L., Hassani, D., Staras, S. A. S., et al. (2013). Do Florida Medicaid providers’ barriers to HPV vaccination vary based on VFC program participation? Maternal and Child Health Journal, 17(4), 609–615.
Markowitz, L. E., Dunne, E. F., Saraiya, M., et al. (2014). Human papillomavirus vaccination: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morbidity and Mortality Weekly Report, 63(5), 1–30.
Moss, J. L., Reiter, P. L., & Brewer, N. T. (2015). Correlates of human papillomavirus vaccine coverage: A state-level analysis. Sexually Transmitted Diseases, 42(2), 71–75.
Opel, D. J., Heritage, J., Taylor, J. A., et al. (2013). The architecture of provider-parent vaccine discussions at health supervision visits. Pediatrics, 132(6), 1037–1046.
Perkins, R. B., Brogly, S. B., Adams, W. G., & Freund, K. M. (2012). Correlates of human papillomavirus vaccination rates in low-income, minority adolescents: A multicenter study. Journal of Women’s Health, 21(8), 813–820.
Petrosky, E., Bocchini, J. A., Hariri, S., et al. (2015). Use of 9-valent human papillomavirus (HPV) vaccine: Updated HPV vaccination recommendations of the Advisory Committee on Immunization Practices. MMWR Morbidity and Mortality Weekly Report, 64(11), 300–304.
Rahman, M., McGrath, C. J., Hirth, J. M., & Berenson, A. B. (2015). Age at HPV vaccine initiation and completion among US adolescent girls: Trend from 2008 to 2012. Vaccine, 33(5), 585–587.
Reagan-Steiner, S., Yankey, D., Jeyarajah, J., et al. (2015). National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years—United States, 2014. MMWR. Morbidity and Mortality Weekly Report, 64(29), 784–792.
Shewchuk, R. M., Carlson, G. L., Klosteman, M., et al. (2014). Frictions as barriers to perioperative alignment: Results from a latent class analysis. Quality Management in Health care, 23(3), 188–200.
U.S. Department of Health and Human Services. (2014). Accelerating HPV vaccine uptake: Urgency for action to prevent cancer. A report to the President of the United States from the President’s Cancer Panel. Bethesda, MD: National Cancer Institute.
Vadaparampil, S. T., Malo, T. L., Kahn, J. A., et al. (2014). Physicians’ human papillomavirus vaccine recommendations, 2009 and 2011. American Journal of Preventive Medicine, 46(1), 80–84.
Vermunt, J. K., & Magdison, J. (2002). Latent class analysis. In J. A. Hagernaars & A. L. McCutcheon (Eds.), Applied latent class analysis (pp. 89–106). Cambridge, UK: Cambridge University Press.
Ylitalo, K. R., Lee, H., & Mehta, N. K. (2013). Health care provider recommendation, human papillomavirus vaccination, and race/ethnicity in the US National Immunization Survey. American Journal of Public Health, 103(1), 164–169.
Zimet, G. D., Rosberger, Z., Fisher, W. A., et al. (2013). Beliefs, behaviors and HPV vaccine: Correcting the myths and the misinformation. Preventive Medicine, 57(5), 414–418.
Acknowledgments
Funding for this study was provided by the National Institute of Allergy and Infectious Diseases (NIAID), Grant R03 AI090499 (PI: Kulczycki). Views expressed herein are those of the authors and do not necessarily reflect those of NIAID or other institutions.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflicts of interest to report.
Rights and permissions
About this article
Cite this article
Kulczycki, A., Qu, H. & Shewchuk, R. Recommend, but also Discuss: Different Patterns of Physician-Perceived Barriers to Discussing HPV Vaccination and Their Association with Vaccine Administration in 11–12 Year-Old Girls. Matern Child Health J 20, 2539–2547 (2016). https://doi.org/10.1007/s10995-016-2079-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10995-016-2079-9